Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Streptococcus. --- Streptococcus --- Genetics.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Streptococcus Agalactiae --- Streptococcus Agalactiae

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Streptococcus --- Congresses.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This World Health Organization (WHO) report discusses the development and value of Group B streptococcus (GBS) vaccines for maternal immunization, particularly in low- and middle-income countries. It highlights the significant global burden of GBS, which includes neonatal and infant infections, stillbirths, and maternal infections, with the highest impact in sub-Saharan Africa and South Asia. The report emphasizes the potential decline in morbidity and mortality with the introduction of a maternal vaccine, which could yield positive economic benefits if affordably priced. It also outlines the need for increased awareness, strengthened health systems, and filling information gaps to improve vaccine implementation and impact assessment. The intended audience includes vaccine developers, funders, policymakers, and health planners.

Vaccines. --- Streptococcus.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Résumé

STREPTOCOCCUS AGALACTIAE --- GENETICS --- STREPTOCOCCUS AGALACTIAE --- GENETICS